The synthesis of Gabapentin, a widely used antiepileptic and analgesic drug, relies heavily on the availability of high-quality precursors. Among these, 1,1-Cyclohexanediacetic Acid (CAS 4355-11-7) stands out as a critical intermediate. For pharmaceutical companies aiming to optimize their Gabapentin production, securing a consistent supply of this intermediate with stringent purity is non-negotiable. Our role as a dedicated chemical manufacturer is to provide precisely that: a reliable source of this essential building block.

The efficacy of Gabapentin directly correlates with the purity of its starting materials. Consequently, pharmaceutical formulators and procurement specialists actively seek 1,1-cyclohexanediacetic acid suppliers who can guarantee an assay of ≥99% and a consistent physical form, typically a white crystalline powder. The CAS number 4355-11-7 serves as a universal identifier, ensuring that you receive the exact chemical entity required for your synthesis. We understand the critical nature of this intermediate and maintain rigorous quality control throughout our production process to meet these exacting demands.

When evaluating potential suppliers, it is crucial to look for a manufacturer that demonstrates a deep understanding of pharmaceutical synthesis requirements. Factors such as production capacity, adherence to Good Manufacturing Practices (GMP), and the ability to provide comprehensive documentation (like Certificates of Analysis) are vital. As a seasoned pharmaceutical intermediate provider, we are committed to supporting your R&D and commercialization efforts. We encourage you to inquire about our capabilities and the price of 1,1-cyclohexanediacetic acid for your specific project needs.

By choosing a dependable supplier for your 1,1-Cyclohexanediacetic Acid, you not only ensure the quality of your Gabapentin but also streamline your supply chain. This focus on quality upstream translates directly into greater efficiency and reliability downstream. We are poised to be your trusted partner, offering the critical intermediate that powers your pharmaceutical innovation.